Parker Paul Gray has filed 10 insider transactions across 2 companies since November 2023.
Most recent transaction: a grant/award of 29561 shares of Generate Biomedicines, Inc. ($GENB) on February 26, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | Generate Biomedicines, Inc. | $GENB | Parker Paul Gray | Not found | A | Stock Option (Right to Buy) | 29561 | $0.00 | 29,561.0000 | 0 | 9999.99% | 0.00% |
| Aug. 30, 2024 | CLOROX CO /DE/ | $CLX | Parker Paul Gray | Director | A | Deferred Stock Units | 25 | $0.00 | 3,280.6315 | 130,741,000 | 0.77% | 0.00% |
| Sept. 30, 2024 | CLOROX CO /DE/ | $CLX | Parker Paul Gray | Director | A | Common Stock | 80 | $162.91 | 978.0000 | 130,741,000 | 8.91% | 0.00% |
| June 28, 2024 | CLOROX CO /DE/ | $CLX | Parker Paul Gray | Director | A | Common Stock | 96 | $136.47 | 898.0000 | 0 | 11.97% | 0.00% |
| May 10, 2024 | CLOROX CO /DE/ | $CLX | Parker Paul Gray | Director | A | Deferred Stock Units | 27 | $0.00 | 3,255.5430 | 0 | 0.84% | 0.00% |
| March 28, 2024 | CLOROX CO /DE/ | $CLX | Parker Paul Gray | Director | A | Common Stock | 85 | $153.11 | 802.0000 | 0 | 11.85% | 0.00% |
| Feb. 9, 2024 | CLOROX CO /DE/ | $CLX | Parker Paul Gray | Director | A | Deferred Stock Units | 25 | $0.00 | 3,228.5167 | 0 | 0.78% | 0.00% |
| Dec. 29, 2023 | CLOROX CO /DE/ | $CLX | Parker Paul Gray | Director | A | Common Stock | 92 | $142.59 | 717.0000 | 0 | 14.72% | 0.00% |
| Nov. 9, 2023 | CLOROX CO /DE/ | $CLX | Parker Paul Gray | Director | A | Deferred Stock Units | 19 | $0.00 | 2,086.0708 | 0 | 0.91% | 0.00% |
| Dec. 29, 2023 | CLOROX CO /DE/ | $CLX | Parker Paul Gray | Director | A | Deferred Stock Units | 1117 | $0.00 | 3,203.4246 | 0 | 53.56% | 0.00% |